Proinflammatory cytokines induce cyclooxygenase-2 mRNA and protein expression in human pulp cell cultures

J Endod. 2003 Mar;29(3):201-4. doi: 10.1097/00004770-200303000-00009.

Abstract

The increased release of prostaglandins (PG) within pulpal tissues is considered to play a pathogenic role during pulpal disease progression. The rate-limiting step in the formation of PG from arachidonic acid is catalyzed by cyclooxygenase (COX). COX-2 is an inducible enzyme believed to be responsible for PG synthesis at site of inflammation. The effect of proinflammatory cytokines on human pulp cells with special reference to COX-2 expression has not been reported earlier. The aim of the present study was to investigate the effects of interleukin (IL)-1alpha and tumor necrosis factor-alpha (TNF-alpha) on the expression of COX-2 mRNA gene and protein in cultured human pulp cells. Investigations of the time dependence of COX-2 mRNA expression in proinflammatory cytokines-treated human pulp cells revealed a rapid accumulation of the transcript, a significant signal first detectable 1 h after exposure. In addition, both IL-1alpha and TNF-alpha up-regulated COX-2 protein expression by human pulp cells. The kinetics of this response showed that COX-2 was detectable in cell lysates as early as 2 h post proinflammatory cytokines challenge and remained elevated throughout the 24-h incubation period. This suggests that one of the pathogenic mechanisms of pulpal inflammation in vivo may be the synthesis of COX-2 by resident cells in response to a proinflammatory cytokines challenge. COX-2 may play an important role in the regulation of prostanoid formation in the pathogenesis of pulpal inflammation. Taken together, we propose that the use of selective COX-2 inhibitors might provide a valuable tool in the control of pulpal inflammation.

MeSH terms

  • Cell Culture Techniques
  • Cyclooxygenase 2
  • Dental Pulp / drug effects*
  • Dental Pulp / enzymology
  • Enzyme Induction / drug effects
  • Enzyme Induction / genetics
  • Gene Expression Regulation, Enzymologic / drug effects
  • Humans
  • Inflammation Mediators / pharmacology*
  • Interleukin-1 / pharmacology*
  • Isoenzymes / drug effects*
  • Isoenzymes / genetics
  • Membrane Proteins
  • Peroxidases / drug effects*
  • Peroxidases / genetics
  • Prostaglandin-Endoperoxide Synthases / drug effects*
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Pulpitis / enzymology
  • Pulpitis / etiology
  • RNA, Messenger / drug effects*
  • RNA, Messenger / genetics
  • Time Factors
  • Transcription, Genetic / genetics
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Up-Regulation

Substances

  • Inflammation Mediators
  • Interleukin-1
  • Isoenzymes
  • Membrane Proteins
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Peroxidases
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases